CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.94	8.24	9	7.79	10.11	37.31
Short-Term Investments	4.98	12.63	29.92	-	12.41	-
Cash & Short-Term Investments	12.92	20.86	38.92	7.79	22.52	37.31
Cash Growth	-63.33%	-46.39%	399.46%	-65.40%	-39.64%	101.53%
Other Receivables	-	0.43	2.25	0.92	-	-
Total Trade Receivables	-	0.43	2.25	0.92	-	-
Other Current Assets	2.19	1.59	1.91	1.26	0.11	0.51
Total Current Assets	15.11	22.88	43.08	9.96	22.64	37.82
Other Long-Term Assets	-	-	-	0.01	-	0.02
Total Assets	15.11	22.88	43.08	9.97	22.64	37.84
Accounts Payable	2.27	1.45	1.51	0.66	1.13	0.95
Accrued Expenses	2.22	3.2	2.37	1.93	1.29	1.98
Total Current Liabilities	4.5	4.66	3.88	2.6	2.42	2.93
Total Liabilities	4.5	4.66	3.88	2.6	2.42	2.93
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	116.27	115.91	109.87	61.81	165.85	164.92
Accumulated Other Comprehensive Income	-0	0.01	0.06	-	-0.04	-
Retained Earnings	-105.66	-97.7	-70.73	-54.44	-145.6	-130.01
Shareholders' Equity	10.62	18.22	39.2	7.38	20.22	34.91
Total Liabilities & Equity	15.11	22.88	43.08	9.97	22.64	37.84
Net Cash (Debt)	12.92	20.86	38.92	7.79	22.52	37.31
Net Cash Growth	-38.06%	-46.39%	399.46%	-65.40%	-39.64%	103.16%
Net Cash Per Share	1.40	2.31	4.82	2.93	43.47	51.99
Book Value	10.62	18.22	39.2	7.38	20.22	34.91
Book Value Per Share	1.15	2.02	4.86	2.77	39.02	48.64
Tangible Book Value	10.62	18.22	39.2	7.38	20.22	34.91
Tangible Book Value Per Share	1.15	2.02	4.86	2.77	39.02	48.64

SEC Filings: 10-K · 10-Q